RC: 640303

NOTORE CHEMICAL INDUSTRIES PLC UNAUDITED INTERIM FINANCIAL STATEMENTS

FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021

NOTORE CHEMICAL INDUSTRIES PLC

UNUADITED INTERIM FINANCIAL STATEMENTS

FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021

Page

Financial statements

Consolidated statements of profit or loss and other comprehensive income for Q5 2021

1

Consolidated statements of profit or loss and other comprehensive income for fifteen months ended 31 December 2021

2

Consolidated statements of financial position

3

Statements of changes in equity

4

Statements of cash flows

6

Note

Notes to the financial statements

1.0

General information

7

2.0

Basis of preparation and adoption of IFRSs

7

3.0

Changes in accounting policy and disclosures

7

4.0

Summary of significant accounting policies

8

4.1

Foreign currency translation

8

4.2

Trade receivables

8

4.3

Revenue recognition

8

4.4

Cash and cash equivalents

9

4.5

Inventories

9

4.6

Non-current assets held for sale

9

4.7

Trade payables

9

4.8

Provisions and contingent liabilities

9

4.9

Property, plant and equipment

9

4.10

Intangible assets

10

4.11

Impairment of non-financial assets

10

4.12

Financial instruments

11

4.13

Offsetting financial instruments

12

4.14

Impairment of financial assets

12

4.15

Share capital

12

4.16

Income taxation

12

4.17

Employee benefits

13

4.18

Leases

13

4.19

Government grants

14

4.20

Cost of sales

14

4.21

Borrowings

14

4.22

Borrowings costs

14

4.23

Investment property

14

4.24

Consolidation

14

4.25

Segment reporting

15

4.26

Export expansion grant and Negotiable duty credit certificates

15

4.27

Related parties

15

5

Critical accounting estimates and judgements

15

6

Financial risk management

17

7

Revenue from contracts with customers

18

8

Cost of sales

18

9a

Administrative expenses

18

9b

Selling and distribution expenses

19

10

Other income

19

11

Finance income and costs

19

12

Income tax expense

20

13

Earnings per share (EPS)

21

14

Property, plant and equipment

22

15

Right of use assets

23

16

Investment property

23

17

Intangible assets

23

18

Inventories

23

19

Trade and other receivables

24

20

Cash and cash equivalents

24

21

Share capital

24

22

Retained earnings

24

23

Employee benefit obligations

25

24

Borrowings

26

25

Trade and other payables

27

26

Related party transactions

27

27

Investments in subsidiaries

28

28

Revenue from contracts with customers(Three months)

29

29

Cost of sales(Three months)

29

30a

Administrative expenses(Three months)

29

30b

Selling and distribution expenses(Three months)

30

31

Other income(Three months)

30

32

Finance income and costs(Three months)

30

33

Securities Trading Policy

30

NOTORE CHEMICAL INDUSTRIES PLC

UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

FOR THE THREE MONTHS PERIOD ENDED 31 DECEMBER 2021

(All amounts are in thousands of Naira, unless otherwise stated)

Group

Company

Three months

Three months

Three months

Three months

Note

31 Dec 2021

31 Dec 2020

31 Dec 2021

31 Dec 2020

N'000

N'000

N'000

N'000

Revenue from contracts with customers

28

9,558,684

3,569,894

9,205,115

3,308,224

Cost of sales

29

(6,655,957)

(4,962,585)

(6,655,957)

(4,854,546)

Gross profit

2,902,727

(1,392,691)

2,549,158

(1,546,322)

Administrative expenses

30a

(1,211,215)

(1,425,342)

(1,137,091)

(1,358,798)

Selling and distribution expenses

30b

(53,254)

(26,140)

(52,415)

(26,140)

Other income

31

10,372,105

363,386

10,490,350

363,366

Operating income

12,010,362

(2,480,788)

11,850,002

(2,567,894)

Finance income

32

-

96

-

96

Finance cost

32b

(12,072,042)

(4,083,890)

(12,072,042)

(4,083,890)

Exceptional Item

32b

-

-

Finance costs - (net)

32

(12,072,041)

(4,083,793)

(12,072,041)

(4,083,793)

Loss before income tax

(61,679)

(6,564,581)

(222,040)

(6,651,688)

Income tax

-

-

-

-

Profit/(loss) for the period

(61,679)

(6,564,581)

(222,040)

(6,651,688)

Other comprehensive income:

Items that will not be reclassified to profit or loss

Total items that will not be reclassified to profit or loss

-

-

-

-

Items that may be subsequently reclassified to profit or loss

Currency translation difference

(44,672)

370

-

-

Total items that may be reclassified to profit or loss

(44,672)

370

-

-

Other comprehensive income / (loss) for the period-

net of tax

(44,672)

370

-

-

Total comprehensive profit / (loss) for the period

(106,352)

(6,564,211)

(222,040)

(6,651,688)

Total comprehensive profit /(loss) for the year attributable to:

Equity holders of the parent company

(106,352)

(6,564,211)

(222,040)

(6,651,688)

Non controlling interest

-

-

-

-

Earnings per share for loss attributable to the equity

holders of the company

Basic EPS (Naira)

(0.04)

(4.07)

(0.14)

(4.13)

1

NOTORE CHEMICAL INDUSTRIES PLC

UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021

(All amounts are in thousands of Naira, unless otherwise stated)

Group

Company

Fifteen months

Twelve months

Fifteen months

Twelve months

Note

31 Dec 2021

30 Sept 2020

31 Dec 2021

30 Sept 2020

N'000

N'000

N'000

N'000

Revenue from contracts with customers

7

27,025,385

18,799,043

25,484,426

18,799,043

Cost of sales

8

(28,696,351)

(21,678,653)

(27,991,343)

(21,678,653)

Gross profit

(1,670,966)

(2,879,610)

(2,506,917)

(2,879,610)

Administrative expenses

9a

(6,955,713)

(6,016,297)

(6,537,019)

(5,997,731)

Selling and distribution expenses

9b

(272,047)

(293,696)

(266,707)

(293,696)

Other income

10

17,266,551

18,675,245

17,939,101

18,675,245

Operating income

8,367,825

9,485,642

8,628,458

9,504,208

Finance income

11a

388

1,074

388

1,074

Finance cost

11b

(28,770,914)

(23,409,290)

(28,770,914)

(23,409,290)

Finance costs - (net)

11

(28,770,526)

(23,408,216)

(28,770,526)

(23,408,216)

Loss before income tax

(20,402,701)

(13,922,574)

(20,142,068)

(13,904,008)

Income tax

-

7,525,938

-

7,525,938

Profit/(loss) for the period

(20,402,701)

(6,396,636)

(20,142,068)

(6,378,070)

Other comprehensive income:

Items that will not be reclassified to profit or loss

Remeasurement of employee benefit obligations

-

(371,864)

-

(371,864)

Deferred tax credit/(charge) on actuarial loss/gain

-

111,559

-

111,559

Revaluation surplus on property, plant and equipment

-

233,472

-

233,472

Deferred tax charge on revaluation surplus

-

(70,042)

-

(70,042)

Total items that will not be reclassified to profit or loss

-

(96,875)

-

(96,875)

Items that may be subsequently reclassified to profit or loss

Currency translation difference

-

27,621

-

-

Total items that may be reclassified to profit or loss

-

27,621

-

-

Other comprehensive income / (loss) for the period-

net of tax

-

(69,254)

-

(96,875)

Total comprehensive profit / (loss) for the period

(20,402,701)

(6,465,890)

(20,142,068)

(6,474,945)

Total comprehensive profit /(loss) for the year attributable to:

Equity holders of the parent company

(20,402,701)

(6,465,890)

(20,142,068)

(6,474,945)

Non controlling interest

-

-

-

-

Earnings per share for loss attributable to the equity

holders of the company

Basic EPS (Naira)

13

(12.66)

(3.97)

(12.49)

(3.96)

The notes on pages 7 to 30 are an integral part of these financial statements.

2

NOTORE CHEMICAL INDUSTRIES PLC

UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

AS AT 31 DECEMBER 2021

(All amounts are in thousands of Naira, unless otherwise stated)

Group

Company

30 Sept 2020

30 Sept 2020

Note

31 Dec 2021

Restated

31 Dec 2021

Restated

N'000

N'000

N'000

N'000

Non-current assets

Property, plant and equipment

14

148,640,207

145,278,255

148,640,207

145,278,254

Right of use assets

15(a)

30,429

152,647

30,429

152,647

Investment property

16

68,333,559

53,174,118

68,333,559

53,174,118

Intangible asset

17

-

12,509

-

12,509

Investments in subsidiaries

27

-

-

50,255

50,255

Total non-current assets

217,004,195

198,617,529

217,054,450

198,667,783

Current assets

Inventories

18

9,978,056

5,950,222

9,937,080

5,950,222

Trade and other receivables

19

4,631,971

11,315,718

4,917,085

11,315,718

Pledged assets

19

4,540,129

4,540,129

4,540,129

4,540,129

Cash at bank and in hand

20

1,164,890

337,347

1,029,885

336,207

Total current assets

20,315,046

22,143,416

20,424,179

22,142,276

Total assets

237,319,241

220,760,945

237,478,629

220,810,059

Equity

Ordinary shares

21

806,033

806,033

806,033

806,033

Share premium

27,995,916

27,995,916

27,995,916

27,995,916

Asset revaluation reserves

60,531,534

63,961,570

60,531,534

63,961,570

Foreign currency translation reserve

-

544,995

-

-

Retained earnings

22

(46,217,611)

(29,164,393)

(45,967,914)

(29,255,882)

Treasury shares reserve

(1,080,831)

(1,080,831)

(1,080,831)

(1,080,831)

Total equity

42,035,041

63,063,290

42,284,738

62,426,806

Liabilities

Non-current liabilities

Borrowings

24a

79,962,615

89,669,185

79,962,615

89,669,185

Employee benefit obligation

23

1,895,681

1,620,322

1,895,681

1,620,322

Grant liability

24b

2,596,828

4,026,113

2,596,828

4,026,113

Deferred tax liability

12b

10,247,000

10,247,000

10,247,000

10,247,000

Total non-current liabilities

94,702,124

105,562,620

94,702,124

105,562,620

Current liabilities

Borrowings

24a

49,102,306

18,681,317

49,102,306

18,681,317

Lease liability

15(b)

-

135,120

-

135,120

Trade and other payables

25

50,312,526

32,076,683

50,222,220

32,762,281

Grant liability

24b

1,167,241

1,202,959

1,167,241

1,202,959

Current tax liabilities

12

(1)

38,956

(1)

38,956

Total current liabilities

100,582,072

52,135,035

100,491,766

52,820,633

Total liabilities

195,284,196

157,697,655

195,193,890

158,383,253

Total equity and liabilities

237,319,241

220,760,945

237,478,629

220,810,059

The financial statements on pages 1 to 30 were approved and authorised for issue by the board of directors on 28 January 2022 and signed on its behalf by:

Mr. Ohis Ohiwerei

Mr. Onajite P. Okoloko

Mr. Bolarin Tolujo

Managing Director/CEO

Director

Chief Financial Officer

FRC/2017/CIBN/00000016412

FRC/2014/NIM/00000007662

FRC/2018/ICAN/00000018981

The notes on pages 7 to 30 are an integral part of these financial statements.

3

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Notore Chemical Industries plc published this content on 28 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2022 18:52:00 UTC.